表紙
市場調查報告書
商品編碼
232825

骨關節炎疼痛:開發中產品分析

Osteoarthritis (Musculoskeletal) - Drugs In Development, 2021

出版日期: | 出版商: Global Markets Direct | 英文 480 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

骨關節炎疼痛,是隨著軟骨的損傷而發病的伴隨骨關節炎最常見的症狀。

本報告提供骨關節炎止痛藥開發平台現狀及最新更新的各開發階段比較分析,提供您包含最新新聞和發表之企業和研究機關開發中治療藥,治療藥評估及中止的計劃等相關資訊。

簡介

  • 調查範圍

骨關節炎疼痛概要

治療藥的開發

  • 開發中產品的概要
  • 骨關節炎疼痛:企業開發中的治療藥
  • 骨關節炎疼痛:大學/機關研究中的治療藥
  • 骨關節炎疼痛:企業開發中的產品
  • 骨關節炎疼痛:大學/機關研究中的產品

骨關節炎疼痛:治療藥的評估

  • 標的別
  • 各作用機制
  • 各給藥途徑
  • 各分子類型

骨關節炎疼痛的開發治療藥的企業

  • AbbVie Inc
  • Addex Therapeutics Ltd
  • Allergan Plc
  • Ampio Pharmaceuticals Inc
  • Antibe Therapeutics Inc
  • Aralez Pharmaceuticals Inc
  • Arena Pharmaceuticals Inc
  • Array BioPharma Inc
  • Astellas Pharma Inc.
  • Axsome Therapeutics Inc
  • BELLUS Health Inc
  • Boehringer Ingelheim GmbH
  • Cara Therapeutics Inc
  • Chromocell Corp
  • Eli Lilly and Company
  • Elite Pharmaceuticals Inc
  • Eupraxia Pharmaceuticals Inc
  • Flexion Therapeutics Inc
  • Genzyme Corp
  • GlaxoSmithKline Plc
  • Grunenthal GmbH
  • Iroko Pharmaceuticals LLC
  • Marina Biotech Inc
  • Medestea Research & Production SpA
  • MedImmune LLC
  • Merck & Co Inc
  • Nuvo Pharmaceuticals Inc
  • 小野藥品工業
  • Pfizer Inc
  • Phosphagenics Ltd
  • ProteoThera Inc
  • pSivida Corp
  • Purdue Pharma LP
  • Regeneron Pharmaceuticals Inc
  • Rottapharm Biotech Srl
  • Shionogi & Co Ltd
  • Symic Biomedical Inc
  • Taiwan Liposome Company Ltd
  • Vertex Pharmaceuticals Inc
  • Zynerba Pharmaceuticals Inc

藥物簡介

骨關節炎疼痛:暫停中的計劃

骨關節炎疼痛:開發中止的產品

骨關節炎疼痛:產品開發的里程碑

  • 主要消息和新聞稿

附錄

圖表

目錄
Product Code: GMDHC12891IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Drugs In Development, 2021, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape.

Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery, medications like non-steroidal anti-inflammatory drugs (NSAIDs) and exercise.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Osteoarthritis - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Osteoarthritis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 13, 36, 23, 2, 4, 61, 15 and 2 respectively. Similarly, the Universities portfolio in Phase III, Phase I, Preclinical and Discovery stages comprises 1, 2, 8 and 7 molecules, respectively.

Osteoarthritis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoarthritis (Musculoskeletal Disorders).
  • The pipeline guide reviews pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Osteoarthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Osteoarthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders)

Reasons to Buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Osteoarthritis (Musculoskeletal Disorders).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Osteoarthritis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

  • Introduction
  • Osteoarthritis - Overview
  • Osteoarthritis - Therapeutics Development
  • Osteoarthritis - Therapeutics Assessment
  • Osteoarthritis - Companies Involved in Therapeutics Development
  • Osteoarthritis - Drug Profiles
  • Osteoarthritis - Dormant Projects
  • Osteoarthritis - Discontinued Products
  • Osteoarthritis - Product Development Milestones
  • Appendix

List of Tables

List of Tables

  • Number of Products under Development for Osteoarthritis, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Osteoarthritis - Pipeline by 4P-Pharma SAS, 2021
  • Osteoarthritis - Pipeline by Abiogen Pharma SpA, 2021
  • Osteoarthritis - Pipeline by Achelios Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by Aclaris Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by Adare Pharma Solutions, 2021
  • Osteoarthritis - Pipeline by Akaal Pharma Pty Ltd, 2021
  • Osteoarthritis - Pipeline by Akan Biosciences LLC, 2021
  • Osteoarthritis - Pipeline by AKL Research and Development Ltd, 2021
  • Osteoarthritis - Pipeline by Algomedix Inc, 2021
  • Osteoarthritis - Pipeline by Amgen Inc, 2021
  • Osteoarthritis - Pipeline by Amplicore Inc, 2021
  • Osteoarthritis - Pipeline by Amzell BV, 2021
  • Osteoarthritis - Pipeline by AskAt Inc, 2021
  • Osteoarthritis - Pipeline by Asta Pharmaceuticals Co Ltd, 2021
  • Osteoarthritis - Pipeline by Atlanthera, 2021
  • Osteoarthritis - Pipeline by Aurealis Pharma AG, 2021
  • Osteoarthritis - Pipeline by Axsome Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by Bioiberica SAU, 2021
  • Osteoarthritis - Pipeline by BioIntegrate Inc, 2021
  • Osteoarthritis - Pipeline by BioNet Pharma GmbH, 2021
  • Osteoarthritis - Pipeline by Bioorg3.14 LLC, 2021
  • Osteoarthritis - Pipeline by BioSplice Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by BioStem Technologies Inc, 2021
  • Osteoarthritis - Pipeline by Bioventus Inc, 2021
  • Osteoarthritis - Pipeline by Bone Therapeutics SA, 2021
  • Osteoarthritis - Pipeline by BRIM Biotechnology Inc, 2021
  • Osteoarthritis - Pipeline by CAR-T (Shanghai) Biotechnology Co Ltd, 2021
  • Osteoarthritis - Pipeline by CarthroniX Inc, 2021
  • Osteoarthritis - Pipeline by Cartilagen Inc, 2021
  • Osteoarthritis - Pipeline by Causeway Therapeutics Ltd, 2021
  • Osteoarthritis - Pipeline by Cells for Cells SA, 2021
  • Osteoarthritis - Pipeline by CellTex Therapeutics Corp, 2021
  • Osteoarthritis - Pipeline by Cellular Biomedicine Group Inc, 2021
  • Osteoarthritis - Pipeline by Chondrogenix Ltd, 2021
  • Osteoarthritis - Pipeline by Cmxtwenty, 2021
  • Osteoarthritis - Pipeline by Cocoon Biotech, Inc., 2021
  • Osteoarthritis - Pipeline by Corestem Inc, 2021
  • Osteoarthritis - Pipeline by Cynata Therapeutics Ltd, 2021
  • Osteoarthritis - Pipeline by Cytonics Corp, 2021
  • Osteoarthritis - Pipeline by Daewoong Pharmaceutical Co Ltd, 2021
  • Osteoarthritis - Pipeline by Dianomi Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by DNX Biopharmaceuticals Inc, 2021
  • Osteoarthritis - Pipeline by Dongkook Pharmaceutical Co Ltd, 2021
  • Osteoarthritis - Pipeline by Eli Lilly and Co, 2021
  • Osteoarthritis - Pipeline by Ensol Biosciences Inc, 2021
  • Osteoarthritis - Pipeline by Eternity Bioscience Inc, 2021
  • Osteoarthritis - Pipeline by Evgen Pharma Plc, 2021
  • Osteoarthritis - Pipeline by Flexion Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by Genascence Corp, 2021
  • Osteoarthritis - Pipeline by Genequine Biotherapeutics GmbH, 2021
  • Osteoarthritis - Pipeline by General Regeneratives Shanghai Ltd, 2021
  • Osteoarthritis - Pipeline by GlaxoSmithKline Plc, 2021
  • Osteoarthritis - Pipeline by Gwoxi Stem Cell Applied Technology Co Ltd, 2021
  • Osteoarthritis - Pipeline by Haplnscience Inc, 2021
  • Osteoarthritis - Pipeline by Hisamitsu Pharmaceutical Co Inc, 2021
  • Osteoarthritis - Pipeline by Histogen Inc, 2021
  • Osteoarthritis - Pipeline by Hope Biosciences LLC, 2021
  • Osteoarthritis - Pipeline by iCELL Biotechnology Co Ltd, 2021
  • Osteoarthritis - Pipeline by ICM Co Ltd, 2021
  • Osteoarthritis - Pipeline by Inception Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by InKemia IUCT Group SA, 2021
  • Osteoarthritis - Pipeline by International Stem Cell Corp, 2021
  • Osteoarthritis - Pipeline by Juniper Biologics Pte Ltd, 2021
  • Osteoarthritis - Pipeline by Juvena Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by Kaken Pharmaceutical Co Ltd, 2021
  • Osteoarthritis - Pipeline by Kang Stem Biotech Co Ltd, 2021
  • Osteoarthritis - Pipeline by Kolon TissueGene Inc, 2021
  • Osteoarthritis - Pipeline by Kukje Pharmaceutical Industry Co Ltd, 2021
  • Osteoarthritis - Pipeline by Levolta Pharmaceuticals Inc, 2021
  • Osteoarthritis - Pipeline by LG Chem Ltd, 2021
  • Osteoarthritis - Pipeline by Likarda LLC, 2021
  • Osteoarthritis - Pipeline by Link Biologics Ltd, 2021
  • Osteoarthritis - Pipeline by Link Health Group, 2021
  • Osteoarthritis - Pipeline by Lubris Biopharma, 2021
  • Osteoarthritis - Pipeline by Luye Pharma Group Ltd, 2021
  • Osteoarthritis - Pipeline by Magellan Biologicals Pty Ltd, 2021
  • Osteoarthritis - Pipeline by MDimune Inc, 2021
  • Osteoarthritis - Pipeline by Mecox Cure Med Co Ltd, 2021
  • Osteoarthritis - Pipeline by Medicrinia Co Ltd, 2021
  • Osteoarthritis - Pipeline by MediPost Co Ltd, 2021
  • Osteoarthritis - Pipeline by Medivir AB, 2021
  • Osteoarthritis - Pipeline by MeiraGTx Holdings Plc, 2021
  • Osteoarthritis - Pipeline by Meluha Life Sciences Sdn Bhd, 2021
  • Osteoarthritis - Pipeline by Merck KGaA, 2021
  • Osteoarthritis - Pipeline by Meridigen Biotech Co Ltd, 2021
  • Osteoarthritis - Pipeline by Mesoblast Ltd, 2021
  • Osteoarthritis - Pipeline by MetrioPharm AG, 2021
  • Osteoarthritis - Pipeline by Mor Research Applications Ltd, 2021
  • Osteoarthritis - Pipeline by Nanode Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by NeuroBo Pharmaceuticals Inc, 2021
  • Osteoarthritis - Pipeline by New York R&D Center for Translational Medicine and Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by Nordic Bioscience AS, 2021
  • Osteoarthritis - Pipeline by Novartis AG, 2021
  • Osteoarthritis - Pipeline by Orbsen Therapeutics Ltd, 2021
  • Osteoarthritis - Pipeline by Organicell Regenerative Medicine Inc, 2021
  • Osteoarthritis - Pipeline by OrthoTrophix Inc, 2021
  • Osteoarthritis - Pipeline by Oxacell AG, 2021
  • Osteoarthritis - Pipeline by Paradigm Biopharmaceuticals Ltd, 2021
  • Osteoarthritis - Pipeline by Parnia Stem Cell Knowledge-Based Co, 2021
  • Osteoarthritis - Pipeline by Peptinov SAS, 2021
  • Osteoarthritis - Pipeline by Personalized Stem Cells Inc, 2021
  • Osteoarthritis - Pipeline by Pfizer Inc, 2021
  • Osteoarthritis - Pipeline by PhytoHealth Corp, 2021
  • Osteoarthritis - Pipeline by Plakous Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by PMG PHARM Co Ltd, 2021
  • Osteoarthritis - Pipeline by PrimRNA Inc, 2021
  • Osteoarthritis - Pipeline by Progenitor Therapeutics Ltd, 2021
  • Osteoarthritis - Pipeline by ProteoThera Inc, 2021
  • Osteoarthritis - Pipeline by Regeneus Ltd, 2021
  • Osteoarthritis - Pipeline by Regenosine Inc, 2021
  • Osteoarthritis - Pipeline by Regulaxis SAS, 2021
  • Osteoarthritis - Pipeline by Ribomic Inc, 2021
  • Osteoarthritis - Pipeline by Rottapharm Biotech Srl, 2021
  • Osteoarthritis - Pipeline by Runjia (Suzhou) Pharmaceutical Technology Co Ltd, 2021
  • Osteoarthritis - Pipeline by Sclnow Biotechnology Co Ltd, 2021
  • Osteoarthritis - Pipeline by Seikagaku Corp, 2021
  • Osteoarthritis - Pipeline by Serene LLC, 2021
  • Osteoarthritis - Pipeline by Shionogi & Co Ltd, 2021
  • Osteoarthritis - Pipeline by SL Bigen Inc, 2021
  • Osteoarthritis - Pipeline by Steminent Biotherapeutics Inc, 2021
  • Osteoarthritis - Pipeline by Stempeutics Research Pvt Ltd, 2021
  • Osteoarthritis - Pipeline by Synartro AB, 2021
  • Osteoarthritis - Pipeline by Synerkine Pharma BV, 2021
  • Osteoarthritis - Pipeline by Synokem Pharmaceuticals Ltd, 2021
  • Osteoarthritis - Pipeline by Taiwan Bio Therapeutics Co Ltd, 2021
  • Osteoarthritis - Pipeline by Techfields Pharma Co Ltd, 2021
  • Osteoarthritis - Pipeline by Traverse Biosciences Inc, 2021
  • Osteoarthritis - Pipeline by Unicocell Biomed Co Ltd, 2021
  • Osteoarthritis - Pipeline by Vitro Diagnostics Inc, 2021
  • Osteoarthritis - Pipeline by WEX Pharmaceuticals Inc, 2021
  • Osteoarthritis - Pipeline by WNT Scientific LLC, 2021
  • Osteoarthritis - Pipeline by Xalud Therapeutics Inc, 2021
  • Osteoarthritis - Pipeline by Xintela AB, 2021
  • Osteoarthritis - Pipeline by Yooyoung Pharm Co Ltd, 2021
  • Osteoarthritis - Pipeline by Zhejiang Yatai Pharmaceutical Co Ltd, 2021
  • Osteoarthritis - Pipeline by Zimmer Biomet Holdings Inc, 2021
  • Osteoarthritis - Dormant Projects, 2021
  • Osteoarthritis - Discontinued Products, 2021

List of Figures

List of Figures

  • Number of Products under Development for Osteoarthritis, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021